Vaccinex Capital Lease Obligations from 2010 to 2024
VCNX Stock | USD 6.00 0.06 1.01% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 146 K | Current Value 164.2 K | Quarterly Volatility 94.7 K |
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 191.5 K, as well as many exotic indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
Vaccinex | Capital Lease Obligations |
Latest Vaccinex's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Vaccinex over the last few years. Vaccinex capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Vaccinex asset purchases. For example, Vaccinex can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Vaccinex control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Vaccinex's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.
Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
Timeline |
Vaccinex Capital Lease Obligations Regression Statistics
Arithmetic Mean | 50,745 | |
Geometric Mean | 0.00 | |
Coefficient Of Variation | 186.67 | |
Mean Deviation | 74,426 | |
Median | 0.00 | |
Standard Deviation | 94,727 | |
Sample Variance | 9B | |
Range | 310K | |
R-Value | 0.70 | |
Mean Square Error | 5B | |
R-Squared | 0.49 | |
Significance | 0 | |
Slope | 14,783 | |
Total Sum of Squares | 125.6B |
Vaccinex Capital Lease Obligations History
About Vaccinex Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Vaccinex income statement, its balance sheet, and the statement of cash flows. Vaccinex investors use historical funamental indicators, such as Vaccinex's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Vaccinex investors may use each financial statement separately, they are all related. The changes in Vaccinex's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vaccinex's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vaccinex Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Capital Lease Obligations | 146 K | 164.2 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaccinex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaccinex's short interest history, or implied volatility extrapolated from Vaccinex options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
CRM | Salesforce | |
GOOG | Alphabet Inc Class C |
Check out the analysis of Vaccinex Correlation against competitors. For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Vaccinex Stock analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Vaccinex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaccinex. If investors know Vaccinex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaccinex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (43.68) | Revenue Per Share 1.229 | Quarterly Revenue Growth (1.00) | Return On Assets (2.46) | Return On Equity (14.05) |
The market value of Vaccinex is measured differently than its book value, which is the value of Vaccinex that is recorded on the company's balance sheet. Investors also form their own opinion of Vaccinex's value that differs from its market value or its book value, called intrinsic value, which is Vaccinex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaccinex's market value can be influenced by many factors that don't directly affect Vaccinex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaccinex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.